Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity, J Virol, vol.86, pp.2045-55, 2012. ,
Antibodies in HIV-1 vaccine development and therapy, Science, vol.341, pp.1199-204, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00861957
Inefficient human immunodeficiency virus replication in mobile lymphocytes, J Virol, vol.81, pp.1000-1012, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00292736
Mechanisms of enhanced HIV spread through T-cell virological synapses, Immunol Reviews, vol.251, pp.113-137, 2013. ,
Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses, J Virol, vol.83, pp.6234-6280, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00458065
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy, Nature, vol.477, pp.95-103, 2011. ,
Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission, J Exp Med, vol.210, pp.2813-2834, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01108608
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys, Nature, vol.503, pp.224-232, 2013. ,
Antibodymediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia, Nature, vol.503, pp.277-80, 2013. ,
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice, Proc Natl Acad Sci, vol.110, pp.16538-16581, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01109449
Les anticorps anti-VIH: multiples activités antivirales, Med Sci (Paris), vol.30, pp.69-75, 2014. ,